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Abstract 
The emerging X-ray structures of the cytochrome bc I complexes from bovine and chicken heart mitochondria support he 
protonmotive Q-cycle as the overall electron- and proton-pathway within the cytochrome bcl complex. The energy 
conserving reaction within this reaction scheme is the unique bifurcation of electron flow into a high potential and a low 
potential pathway occurring at the ubihydroquinone-oxidation ce ter (center P or Qo). This step is prerequisite for the 
'recycling' of every second electron across the membrane onto the ubiquinone-reduction center, which results in vectorial 
proton translocation. It has been shown that during steady-state he step controlling this reaction is the first deprotonation of
ubihydroquinone and not, as proposed earlier, the formation of a highly unstable semiquinone species. Ubiquinone has not 
yet been detected at the ubihydroquinone-oxidation ce ter of the protein structures now available, but the pocket seems 
spacious enough to accommodate wo ubiquinone molecules. This is in line with recent enzymological studies, which have 
shown that not only two ubiquinones, but also two inhibitor molecules can bind to center P. The most striking result from 
the structures i  that the hydrophilic domain of the 'Rieske' protein can be found in two different positions which seem to 
allow electron transfer between the iron-sulfur cluster and either ubiquinone binding at center P or heme c 1 . This provides 
strong support for the 'catalytic switch' model proposed earlier based on detailed analysis of inhibitor binding to 
cytochrome bc~ complex in different redox states. © 1998 Elsevier Science B.V. 
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1. Introduction 
The cytochrome bcl complex forms the middle 
part of the mitochondrial nd many bacterial respira- 
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Abbreviations: cyt b L, low potential cytochrome b; Em, redox 
midpoint potential; EPR, electron spin paramagnetic resonance; 
MOA, E-[3-methoxyacrylate; Qosand Qow, stronger and weaker 
binding ubiquinone molecule at center P. 
tory chains [1-3] and is also part of the photo- 
synthetic electron transfer chains of purple bacteria 
[4]. It is a member of a larger family of bc-type 
complexes, which includes the cytochrome b6f  com- 
plex found in chloroplasts, algae and some Gram- 
positive bacteria [5]. 
The cytochrome bc I complex transfers electrons 
from ubihydroquinone to cytochrome c and links this 
electron transfer to the establishment of a proton 
gradient across the inner mitochondrial or bacterial 
plasma membrane. This reaction is described by the 
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PII: S0005-2728(98)00078-4 
262 U. Brandt / Biochimica et Biophysica Acta 1365 (1998) 261-268 
following equation, in which subscripts 'n' and 'p' 
designate negative and positive sides of the mem- 
brane and 'ox' and 'red' refer to oxidized and 
reduced species: 
2 + c red 4Hp QH 2 + 2cytc  °x + H n ~Q + 2cyt + 
(1) 
Three subunits of the cytochrome bc 1 complex 
contain redox prosthetic groups, the diheme cyto- 
chrome b, cytochrome c 1, and the Rieske iron-sulfur 
protein. Although the cytochrome bcl complexes of 
mitochondria contain multiple additional subunits 
which lack prosthetic groups [3,6], these supernumer- 
ary subunits are not essential for catalysis, as evi- 
denced by the fact that no significant functional 
differences have been found compared to the bacteri- 
al enzyme in which only the three redox proteins are 
present [2]. The subunit composition, topology, struc- 
ture and mutational analysis of the cytochrome bc~ 
complex has been summarized in a number of recent 
reviews [1,4,7-9]. The emerging X-ray structures of 
the cytochrome bc 1 complexes from bovine [10] and 
chicken heart mitochondria [11] support the overall 
picture that had emerged from previous extensive 
studies on this respiratory chain complex. Most 
importantly, the protonmotive Q-cycle [12] as the 
general reaction scheme of the cytochrome bcl 
complex is confirmed by the molecular structure. The 
energy conserving reaction within the Q-cycle re- 
action scheme is the unique bifurcation of electron 
flow into a high potential and a low potential pathway 
occurring at the ubihydroquinone-oxidation ce ter 
(center P or Qo). This step is prerequisite for the 
'recycling' of every second electron across the mem- 
brane onto the ubiquinone-reduction center, which 
results in vectorial proton translocation. It is the 
purpose of this minireview to compile recent ex- 
perimental evidence and mechanistic models for this 
unique reaction and discuss them in the light of the 
emerging molecular structure of the cytochrome bc~ 
complex. 
entirely different acceptors is a unique reaction only 
found in the cytochrome bc I complex. It is in this 
reaction where the actual chemistry takes place that 
drives vectorial proton translocation: one of the two 
electrons is forced to enter the low potential pathway 
according to 
ox ox i', c~red 
QH 2 q- Fe2S 2 + cytb L ~ Q + 1~e2~2 
+ cytb~ d + 2H + 
AG ° '~ - 13 kJ/mol (2) 1 
thereby preventing the thermodynamically much 
more favourable, but unproductive r action 
ox ,.~ r-, ~red  
QH 2 + 2Fe2S 2 ---> Q + zt"e2~ 2 + 2H + 
AG O' ~ - 43 M/mol 1 (3) 2 
Remarkably, the latter reaction is observed not 
even in the so called oxidant-induced reduction 
experiment, where excess of an oxidant like ferri- 
cyanide is added in the presence of substrate and the 
center N inhibitor antimycin and both hemes of 
cytochrome b become almost fully reduced. In other 
words, the fact that antimycin is a very efficient 
inhibitor of the enzyme's teady state demonstrates a 
tight control of the reaction of some kind, leading to 
an obligatory bifurcation of electron flow, which in 
turn is prerequisite to vectorial proton translocation. 
This central question, namely how this control is built 
into the chemistry of the center P reaction, is not 
addressed by the reaction scheme of the protonmotive 
Q-cycle. 
It is evident from Eq. (2) that the driving force for 
ubihydroquinone-oxidation at center P results from 
the highly positive midpoint of the 'Rieske' iron- 
sulfur cluster [13,14] and that the first electron 
transfer must occur from ubihydroquinone onto this 
redox center. This is confirmed by the observation 
that the decrease of the midpoint potential of the 
iron-sulfur cluster induced by mutations in the genes 
encoding the 'Rieske' proteins from Saccharomyces 
cerevisiae [15] and Paracoccus denitrificans [16] 
correlates well with a corresponding decrease in 
2. The chemistry of ubihydroquinone oxidation 
at center P 
The ubihydroquinone oxidation at center P by two 
1Calculated for bovine enzyme using Em7 of +70, +290 and 
-20  mV for QH//Q, FezS 2, and cyt b L respectively. 
2Caculated for bovine enzyme using Era7 o f  +70,  +290 and 
-20  mV for QHe/Q, FezS z, and cyt b L respectively. 
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catalytic rates. However, this thermodynamic rela- 
tionship only provides information on the overall 
reaction, but allows no conclusions on the individual 
intermediates linking ubihydroquinone-oxidation o 
the bifurcated electron flow. Therefore, analysis of 
the properties of these intermediates of 
ubihydroquinone-oxidation is the key to the mecha- 
nism of energy conservation i the cytochrome bcl 
complex. Several mechanistic models have addressed 
this issue in recent years. The key properties of these 
models are summarized in Table 1 and will be 
compared in the following discussion. 
2.1. The number of quinone binding sites at 
center P 
Ding and coworkers have presented a careful study 
analyzing the EPR line shape of the Rieske iron- 
sulfur cluster which indicates that two ubiquinone 
molecules can bind simultaneously to center P of the 
bacterial cytochrome bc~ complex [17,18]. This 
report of a slowly exchanging and more tightly bound 
Qos and a rapidly exchanging and loosely bound Qow 
fits nicely with earlier inhibitor binding studies 
indicating that the noncompetitive E-[3-methoxy- 
acrylates [19] and stigmatellin occupy distinct bind- 
ing sites in a rather spacious pocket formed by the 
Rieske protein and cytochrome b of the mammalian 
cytochrome bc I complex [20]. More recently, it could 
be demonstrated that the fully reduced enzyme has 
two binding sites for E-[3-methoxyacrylate inhibitors 
at center P [21]. 
The information on this issue from the X-ray 
structures i  still rather limited because this part of 
the multiprotein complex seems to be poorly ordered 
and it was not yet possible to identify any electron 
density of ubiquinone at center P [10,11]. However, 
electron densities of several specific inhibitors bound 
to center P have been identified in the mammalian 
and the chicken structure. These data confirm that the 
two classes of center P inhibitors bind to adjacent but 
distinct sites [11]. Stigmatellin was found to be in 
contact with the iron-sulfur ligand histidine-161 
while the E-[3-methoxyacrylate inhibitor myxothiazol 
binds in the vicinity of heme b L [11]. This suggests 
that center P in fact is a rather spacious pocket hat 
could accommodate two ubiquinone headgroups. 
Whether this would be in a stacked or an edge to 
edge configuration remains unclear. However, a 
bridge formed by two edge to edge ubiquinone 
headgroups between two histidine ligands of the 
iron-sulfur cluster and heme b L as suggested in Ref. 
[22] seems to by excluded as in the presence of 
stigmatellin the distance between the two proximal 
nitrogens of these residues is only 19 ,~. 
Although combination of this set of experimental 
data allows the building of quite a good case for two 
molecules of ubiquinone at center P, direct evidence 
will be necessary to resolve this issue. However, 
there is a couple of other issues regarding the 
chemistry of ubihydroquinone oxidation that can and 
should be addressed independently. 
2.2. Properties of the ubisemiquinone at center P 
Transient formation of a highly unstable semi- 
quinone intermediate (Em for QO- /Q=-300-400 
mV) has been proposed and was incorporated into 
kinetic models as the key intermediate controlling the 
first electron transfer [17,23]. Such a highly unstable 
species has been observed by EPR under conditions 
of oxidant-induced reduction in the presence of 
antimycin [24] and was attributed to a semiquinone at
Table 1 
Synopsis of mechanistic models for the chemistry of ubihydroquinone oxidation at center P 
Model No. of 
quinones 
Initial arrangement of quinone(s) Nature of 
transition 
state 
Semiquinone stability References 
Crofts and Wang 1 
Ding and coworkers 2 
Brandt 2 
Link 1 
Not defined 
Preferably edge to edge; H-bonds to heine 
b L and FeS- imidazols 
Stacked; H-bond of Q to FeS-imidazol 
H-bond of QH- to FeS-imidazol 
Qo 
QO-/QO 
or Q*- 
QH- 
QH 
Highly unstable 
Highly unstable 
Partially stabilized 
Stabilized by reduced FeS 
[23] 
[17,18] 
[22] 
[27] 
Q, ubiquinone; QH-, partially deprotonated ubihydroquinone; Qe- ubisemiquinone. 
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center P. However, this assignment is challenged by a 
recent reexamination of this phenomenon revealing 
that this EPR detectable radical is not abolished by 
the addition of center P inhibitors like myxothiazol, 
MOA-stilbene or stigmatellin [25]. Moreover, the 
formation of such a highly unstable semiquinone 
implies that the first electron transfer is markedly 
endergonic. Orii and Miki [26] tried to include a 
corresponding thermodynamic barrier into their 
elaborate kinetic model that takes into account 56 
reaction intermediates of the Q-cycle reaction 
scheme. The result of this simulation was an appreci- 
able deviation from experimental data which seems to 
exclude this possibility. 
A pronounced stabilization of the semiquinone 
intermediate due to tight binding to the reduced 
iron-sulfur cluster is the critical element of the 
'proton-gated affinity change' mechanism proposed 
by Link [27]. According to this model reoxidation of 
the iron-sulfur cluster requires electron transfer to 
heme b E and the semiquinone state should build up 
under the conditions of oxidant-induced reduction in 
the presence of antimycin. The fact that this species 
cannot be observed by EPR spectroscopy could be 
explained by tight magnetic oupling between the 
semiquinone radical and the reduced iron-sulfur 
cluster. 
In contrast, no accumulation of semiquinone is
predicted by the proton-gated charge transfer mecha- 
nism [22] which postulates an exergonic first electron 
transfer and a moderate thermodynamic stabilization 
of the double-semiquinone intermediate. The key 
difference is that in this model the first electron 
transfer is limited by the deprotonation of 
ubihydroquinone and for electrostatic reasons occurs 
rapidly only if the acceptor of the second electron, 
heme b E, is oxidized. This means that semiquinone is 
only formed if it can be oxidized immediately. Thus, 
for kinetic reasons this model predicts a very low 
occupancy of the semiquinone state under all con- 
ditions. 
2.3. Nature of the transition state 
The activation barrier for ubihydroquinone oxida- 
tion is in the range of 30-40 kJ/mol for the 
cytochrome bc~ complexes from different species 
[23,28]. This barrier has been explained by Crofts 
and Wang as representing the formation of a highly 
unstable semiquinone anion at center P [23]. 
The obvious alternative that the first deprotonation 
of ubihydroquinone is the endergonic step and limits 
the rate has been put forward more recently [22,29]. 
The high pK a of 12.3 in 80% ethanol represents a 
thermodynamic barrier in the expected range. This 
barrier could be abolished if the affinity of QH- to 
center P would be markedly higher than that of QH 2. 
An environment designed to stabilize an anionic 
species would almost inevitably also stabilize the 
semiquinone anion. This scenario is the key feature 
of the proton-gated affinity change mechanism [27], 
but is incompatible with the simple kinetically con- 
trolled models involving a highly unstable semi- 
quinone as the transition state [17,23]. 
As discussed above, there is no experimental 
evidence for the formation of a semiquinone inter- 
mediate. In contrast, we have recently demonstrated 
that the activation barrier is strictly pH dependent 
[28]: the observed linear dependence over the range 
from pH 5.4 to 9.2 reflects a control of the reaction 
by a single deprotonation event and extrapolation 
suggests an effective pK a of ubihydroquinone of 12- 
13, i.e., a value very similar to that found in 80% 
ethanol [30]. Between pH 6 and 9 the midpoint 
potential of the iron-sulfur cluster drops by more 
than 100 mV due to deprotonation of its histidine 
ligands [31,32]. However, this has no effect on the 
catalytic rate or the activation barrier [28] as would 
have been expected if the first electron transfer 
controlled the reaction at center P. This provides 
strong support for one of the key features of the 
proton-gated charge transfer mechanism, namely that 
ubihydroquinone d protonation controls the rate of 
the reaction at center P by limiting the concentration 
of QH- [22,28]. It should be stressed that there is no 
contradiction between this scenario and the observa- 
tion that amino acid changes in the environment of 
the iron-sulfur cluster affecting the biophysical prop- 
erties of this redox center change the catalytic activity 
of the cytochrome bc~ complex [15,16]: such muta- 
tions inevitably not only change the midpoint po- 
tential of the cluster but also the associated pK a 
values and the charge distribution within the redox- 
center. According to the proton-gated charge transfer 
mechanism this is expected to affect he catalytic rate 
by weakening the capacity of the iron-sulfur cluster 
U. Brandt / Biochimica et Biophysica Acta 1365 (1998) 261-268 265 
to promote deprotonation f the substrate by acting as 
a Lewis acid [22]. 
The idea of rate limitation by ubihydroquinone 
deprotonation has also been incorporated into the 
proton-gated affinity change mechanism [27] by 
proposing a prebound state of ubihydroquinone that 
moves to another site after deprotonation. 
3. The mechanics of ubihydroquinone oxidation 
at center P 
The idea of a redox-linked conformational change 
of the cytochrome bc I complex, which seems very 
attractive in the light of the emerging molecular 
structures, is rather old. As early as 1967 Baum et al. 
noted that the conformational stability of the cyto- 
chrome bc~ complex increases when the iron-sulfur 
protein becomes reduced and that at the same time 
this protein becomes more susceptible to proteolytic 
digestion [33]. These authors also speculated that 
these observations might indicate involvement of 
different conformational states of the protein during 
catalysis. Based on the observation of specific redox- 
dependent affinity changes for different inhibitors of 
center P we later proposed the 'catalytic switch' 
model that employs two conformational states of 
center P to explain the obligatory bifurcation of 
electron flow at center P [20,34]. It must be stressed 
that this 'mechanical' aspect of the mechanism of 
ubihydroquinone oxidation is complementary to the 
problem of quinone chemistry. In fact, the idea of a 
conformational switch is compatible with all chemi- 
cal mechanisms discussed above in Section 2. 
Although the quality of structural information 
around the Rieske iron-sulfur protein within the 
cytochrome bc 1 complex is still rather limited, a 
rather striking observation was made already. The 
published bovine structure contains no information on 
the structure of this subunit at all as the electron 
density of this part of the complex was too weak in 
the crystallographic model [10]. However, it was 
possible to identify the position of the iron-sulfur 
cluster at a distance of 31 A from the iron atom of 
heme c 1. This distance is about 10 * longer than 
predicted from the observed rate constant of >105 
s -~ for electron transfer between these two redox- 
centers when the empirical 'Dutton-ruler' is applied 
[35]. In the chicken structure [11], the density of the 
Rieske protein is somewhat better defined and it was 
possible to fit the high resolution structure of the 
water soluble fragment of the bovine subunit into the 
electron density [36]. Zhang et al. were able to 
identify two conformations of the Rieske protein 
[11], reflecting a turn by as much as 57 ° of the water 
soluble part around a hinge region connecting it to its 
transmembrane helix. The iron-sulfur cluster to heme 
c I distance is similar to that reported for the bovine 
enzyme in one conformation, but is about 10 ,& 
shorter in the other state. This would allow electron 
transfer between the iron-sulfur cluster and heme c 1 
at the observed rate. In this 'c 1 conformation' the 
cluster is moved away correspondingly from heme b e 
and the region where center P inhibitors bind. To 
match this observation with the theory of electron 
transfer, it is ahnost inevitable to conclude that the 
water soluble domain of the Rieske protein has to 
switch between the two conformations during turn- 
over and a corresponding 'moving Rieske' model has 
been proposed by Zhang et al. [11]. The important 
question arises whether, as suggested by these au- 
thors, the movement is largely a passive diffusion of 
the iron-sulfur protein between two docking sites on 
cytochrome b and c~, or whether redox changes 
trigger a switching between these two states in a 
fashion similar to that proposed in the 'catalytic 
switch' model [20,34]. The latter alternative seems 
more likely as conformational changes linked in 
particular to the redox state of the iron-sulfur cluster 
were demonstrated by a significant body of ex- 
perimental evidence [20,33,34,37,38]. 
Remarkably little modification of the 'catalytic 
switch' model is necessary to accommodate the 
evidence from the high resolution structure. Fig. 1 
shows a schematic representation of a modified 
'catalytic switch' which--apart from the incorpora- 
tion of the arrangement of the subunits now known 
from the crystal structure--differs in only two points 
from the scheme published in [20]: (1) The iron- 
sulfur protein now is the moving part of the switch, 
rather than being connected and disconnected from 
center P by an unknown switching mechanism; (2) In 
the light of the structural evidence the 'FeS-state' has 
been renamed the 'b-position' and the 'b-state' 
renamed the 'cl-position'. 
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1.Reduction of 
FeS-cluster 
triggers switch 
to 'c 1-position' 
> 
A 
4. Reoxidation of ~ 
heme bH via U center N and of n 
heme c I by cyt. cU  
& second cycle [] 
r - -1  
~ 2.FeS-cluster is 
oxidized by 
heme cl and 
heme bL is 
reduced 
3,Electron transfer 
from heine b L to 
heme bH triggers 
switch back to 
'b-position' 
'b-position' 'c I -position' 
Fig. 1. Schematic representation f the 'catalytic switch' mechanism at the ubihydroquinone oxidation center of cytochrome bc, complex. See text for 
further details. The cartoons of the three catalytic subunits and the orientation of the Rieske protein are based on the structure of the chicken enzyme [11]. 
b c, heme be; b. ,  heme b.;  ca, heme ca; FeS, 'Rieske' iron-sulfur cluster; P, positive side; N, negative side. Oxidized and reduced redox centers are shown 
in outline and bold letters, respectively. 
The 'catalytic switch' model was based on exten- 
sive inhibitor binding studies [20,34]. One of the key 
results from these studies was that inhibitor affinity 
switches between two values depending on the redox 
state of the iron-sulfur cluster and cytochrome b. 
This is not related to ubiquinone, as the experiments 
were performed with isolated cytochrome bc  1 com- 
plex containing less than 0.1 mol ubiquinone/mol 
enzyme. Another important conclusion was drawn 
from these experiments and taken as an explanation 
for the noncompetitive type of inhibition of the E-[3- 
methoxyacrylate inhibitors [19], namely that these 
inhibitors favour the 'c~-position', while stigmatellin 
or undecylhydroxynaphthoquinone favour the 'b-po- 
sition' [34]. Remarkably, this is exactly how the two 
positions of the iron-sulfur protein were induced in 
the protein crystals by Zhang at al. [11]. The idea that 
the Rieske protein moves out of center P when 
E-[3-methoxyacrylates are bound also offers a 
straightforward explanation why in contrast o stig- 
matellin these inhibitors have no effect on the EPR 
spectrum of the iron-sulfur cluster and removal of 
this protein does not affect their binding [20,39]. It 
should be stressed that the exact timing between 
electron transfers and conformational transitions will 
depend on the chemistry of ubihydroquinone oxida- 
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tion. However, it is possible to accommodate all 
chemical mechanisms discussed above by slight 
modifications of the scheme shown in Fig. 1. 
The modified 'catalytic switch' mechanism (Fig. 1) 
not only incorporates the movement of the Rieske 
protein into the center P reaction, but assigns a 
specific function to this unusual phenomenon. It
implies that the 'b-position' requires both the iron- 
sulfur center and heme b L to be oxidized (cf. left side 
of Fig. 1) ensuring that ubihydroquinone is only 
oxidized at center P when a bifurcation of electron 
flow is possible. Even when center N is blocked by 
antimycin and heme b L stays reduced while the 
iron-sulfur cluster is oxidized by heme c I the 
complex stays in the 'c~-position' preventing further 
electron transfers. On a molecular level the 'catalytic 
switch' mechanism suggests that the docking site of 
cytochrome b for the Rieske protein changes at least 
slightly in its molecular structure depending on the 
redox state of heme b L and the presence and redox 
state of the Rieske protein. It was proposed that in the 
'b-position' the complex is in a strained conformation 
that is released when the iron-sulfur protein is 
reduced or removed [20]. Improvement of the crystal- 
lographic data of the oxidized and partially reduced 
complex will be necessary to show whether such 
structural differences indeed exist. 
While it is almost inevitable to conclude that the 
hydrophilic domain of the Rieske protein in fact 
moves forth and back between its two positions 
during catalysis [11], it will be essential to demon- 
strate this experimentally. Evidence that the surface 
of cytochrome b at the interface to the Rieske protein 
is critical for catalytic activity comes from a func- 
tionally deficient point mutation of yeast cytochrome 
b (manuscript in preparation): if threonine-265 of 
cytochrome b is mutated to methionine this results in 
almost complete loss of catalytic activity. Neverthe- 
less, neither the midpoint potentials nor the optical or 
EPR spectra of any of the redox components of the 
cytochrome bc~ complex are changed significantly by 
this mutation. Kinetic analysis revealed that electron 
transfer from ubihydroquinone to the iron-sulfur 
cluster is dramatically slowed down. 
The perfectly conserved threonine-265 is located at 
a tip of the ef loop of cytochrome b [11] and is in 
contact with the Rieske protein. The closest residue 
of the Rieske protein is leucine-142 in the 'cl-posi- 
tion' and isoleucine-147 in the 'b-position' with side- 
chain to side-chain distances of 3-4 A. Other res- 
idues that line the inhibitor binding pocket [11 ] or for 
which mutations have been reported that impair 
center P function or confer inhibitor esistance [9] are 
at least 8 ,~ (isoleucine-269) or 16 A (asparagine-256, 
proline-271) away and are not exposed to the iron- 
sulfur protein/cytochrome b interface. In the 'b- 
position' the imidazol-nitrogen proposed to form a 
hydrogen bond to ubiquinone bound to center P is 13 
away. Therefore, mutating threonine-265 is highly 
unlikely to directly affect the center P reaction 
pocket. The unique location of threonine-265 strongly 
suggests that in the mutant protein activity is blocked 
because movement of the Rieske protein is hindered 
by introducing a bulky methionine side-chain at a 
critical spot of the cytochrome b surface. 
4. Conclusions 
The obligatory bifurcation of electron flow at 
center P of the cytochrome bc I complex can be 
explained by a combination of a chemical control of 
ubihydroquinone oxidation and a 'catalytic switch' of 
the Rieske iron-sulfur protein between two positions. 
Improvement of the crystal structures and indepen- 
dent experimental evidence will be needed to decide 
whether one or two quinones take part in the center P
reaction. Irrespective of this question, it can be 
concluded that deprotonation of ubihydroquinone 
forms the activation barrier [22,28] and that the 
semiquinone species is more or less stabilized by the 
active site. It will be critical for the understanding of
the chemistry of ubihydroquinone oxidation to dem- 
onstrate whether in fact a tightly coupled pair of 
semiquinones and the reduced iron-sulfur cluster 
accumulates under conditions of oxidant-induced 
reduction and whether a charge transfer intermediate 
is formed during catalysis. 
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